Boston Scientific (NYSE:BSX) has canceled an agreement to acquire a majority stake in the publicly listed Korean medical device maker M.I.Tech for $230M in a decision attributed to regulatory concerns ...

Original Image Link
Source:www.msn.com

Original Image Link
Source:www.msn.com
Posted: 2023-05-25 04:11:00